Chinese Journal of Antituberculosis ›› 2022, Vol. 44 ›› Issue (3): 273-283.doi: 10.19982/j.issn.1000-6621.20210572
• Original Articles • Previous Articles Next Articles
ZHUANG Li1, MA Zi-feng1, JIANG Yu-wei1, HUANG Xing1, ZHANG Hui-yong2, LU Zhen-hui1, WU Xian-wei1()
Received:
2021-09-26
Online:
2022-03-10
Published:
2022-03-08
Contact:
WU Xian-wei
E-mail:xwwu2020@163.com
Supported by:
CLC Number:
ZHUANG Li, MA Zi-feng, JIANG Yu-wei, HUANG Xing, ZHANG Hui-yong, LU Zhen-hui, WU Xian-wei. Mechanism of traditional Chinese medicine “Qinbudan” in the treatment of pulmonary tuberculosis based on network pharmacology[J]. Chinese Journal of Antituberculosis, 2022, 44(3): 273-283. doi: 10.19982/j.issn.1000-6621.20210572
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20210572
药物 | MOL编号 | 标识 | 活性成分 | 药物 | MOL编号 | 标识 | 活性成分 |
---|---|---|---|---|---|---|---|
黄芩 | MOL001689 | HQ1 | acacetin | 黄芩+ | MOL000358 | A1 | β-sitosterol |
MOL000173 | HQ2 | wogonin | 百部 | MOL000359 | A2 | sitosterol | |
MOL000228 | HQ3 | (2R)-7-hydroxy-5-methoxy-2-phe- nylchroman-4-one | MOL000449 | A3 | stigmasterol | ||
百部 | MOL001558 | BB1 | sesamin | ||||
MOL002714 | HQ4 | Baicalein | |||||
MOL000392 | BB2 | formononetin | |||||
MOL002909 | HQ5 | 5,7,2,5-tetrahydroxy-8,6-dime- thoxyflavone | |||||
MOL005384 | BB3 | suchilactone | |||||
MOL009363 | BB4 | tuberostemonine C | |||||
MOL002910 | HQ6 | carthamidin | |||||
MOL009374 | BB5 | 7-methoxy-3-methyl-2,5-dihydroxy-9,10-dihydrophenanthrene | |||||
MOL002913 | HQ7 | dihydrobaicalin_qt | |||||
MOL002914 | HQ8 | eriodyctiol(flavanone) | MOL009377 | BB6 | bisdehydroneotuberostemonine | ||
MOL002915 | HQ9 | salvigenin | MOL009379 | BB7 | 2-oxostenine | ||
MOL002917 | HQ10 | 5,2',6'-Trihydroxy-7,8-dimethox- yflavone | MOL009380 | BB8 | bisdehydrostemoninine | ||
MOL009381 | BB9 | bisdehydrostemoninine A | |||||
MOL002925 | HQ11 | 5,7,2',6'-Tetrahydroxyflavone | |||||
MOL009382 | BB10 | bisdehydrostemoninine B | |||||
MOL002927 | HQ12 | skullcapflavone Ⅱ | |||||
MOL009386 | BB11 | 3,3'-bis-(3,4-dihydro-4-hydroxy-6-methoxy)-2H-1-benzopyran | |||||
MOL002928 | HQ13 | oroxylin a | |||||
MOL009387 | BB12 | didehydrotuberostemonine | |||||
MOL002932 | HQ14 | panicolin | |||||
MOL009411 | BB13 | protostemotinine | |||||
MOL002933 | HQ15 | 5,7,4'-Trihydroxy-8-methoxyflavone | |||||
MOL009414 | BB14 | sessilifoliamide C | |||||
MOL002934 | HQ16 | neobaicalein | |||||
MOL009423 | BB15 | sessilistemonamine A | |||||
MOL002937 | HQ17 | dihydrooroxylin | |||||
MOL009424 | BB16 | sessilistemonamine B | |||||
MOL000525 | HQ18 | norwogonin | |||||
MOL009430 | BB17 | stemonamide | |||||
MOL000552 | HQ19 | 5,2'-Dihydroxy-6,7,8-trimethoxy- flavone | |||||
MOL009433 | BB18 | stemoninine B | |||||
MOL000073 | HQ20 | ent-Epicatechin | MOL009434 | BB19 | stemoninoamide | ||
MOL001458 | HQ21 | coptisine | 丹参 | MOL001601 | DS1 | 1,2,5,6-tetrahydrotanshinone | |
MOL002879 | HQ22 | diop | MOL001659 | DS2 | poriferasterol | ||
MOL002897 | HQ23 | epiberberine | MOL001942 | DS3 | isoimperatorin | ||
MOL008206 | HQ24 | moslosooflavone | MOL002222 | DS4 | sugiol | ||
MOL012245 | HQ25 | 5,7,4'-trihydroxy-6-methoxyfla- vanone | MOL002651 | DS5 | dehydrotanshinone ⅡA | ||
MOL000569 | DS6 | digallate | |||||
MOL012246 | HQ26 | 5,7,4'-trihydroxy-8-methoxyfla- vanone | |||||
MOL000006 | DS7 | luteolin | |||||
MOL007036 | DS8 | 5,6-dihydroxy-7-isopropyl-1,1-dimethyl-2,3-dihydrophenanthren-4-one | |||||
MOL012266 | HQ27 | rivularin | |||||
丹参 | MOL007041 | DS9 | 2-isopropyl-8-methylphenanthrene-3,4-dione | 丹参 | MOL007100 | DS32 | dihydrotanshinlactone |
MOL007101 | DS33 | dihydrotanshinoneⅠ | |||||
MOL007045 | DS10 | 3α-hydroxytanshinone Ⅱa | |||||
MOL007105 | DS34 | epidanshenspiroketallactone | |||||
MOL007048 | DS11 | (E)-3-[2-(3,4-dihydroxyphenyl)-7-hydroxy-benzofuran-4-yl]acrylic acid | |||||
MOL007107 | DS35 | C09092 | |||||
MOL007108 | DS36 | isocryptotanshi-none | |||||
MOL007049 | DS12 | 4-methylenemiltirone | |||||
MOL007111 | DS37 | isotanshinone Ⅱ | |||||
MOL007050 | DS13 | 2-(4-hydroxy-3-methoxyphenyl)-5-(3-hydroxypropyl)-7-methoxy-3-ben-zofurancarboxaldehyde | |||||
MOL007119 | DS38 | miltionone Ⅰ | |||||
MOL007120 | DS39 | miltionone Ⅱ | |||||
MOL007058 | DS14 | formyltanshinone | |||||
MOL007122 | DS40 | miltirone | |||||
MOL007059 | DS15 | 3-β-Hydroxymethyllenetanshiquinone | |||||
MOL007124 | DS41 | neocryptotanshinoneⅡ | |||||
MOL007061 | DS16 | methylenetanshinquinone | |||||
MOL007125 | DS42 | neocryptotanshinone | |||||
MOL007063 | DS17 | przewalskin a | |||||
MOL007127 | DS43 | 1-methyl-8,9-dihydro-7H-naphtho[5,6-g]benzofuran-6,10,11-trione | |||||
MOL007064 | DS18 | Przewalskin b | |||||
MOL007130 | DS44 | prolithospermic acid | |||||
MOL007068 | DS19 | przewaquinone B | |||||
MOL007132 | DS45 | (2R)-3-(3,4-dihydroxyphenyl)-2-[(Z)-3-(3,4-dihydroxyphenyl)acryloyl]oxy-propionic acid | |||||
MOL007069 | DS20 | przewaquinone c | |||||
MOL007070 | DS21 | (6S,7R)-6,7-dihydroxy-1,6-dimethyl-8,9-dihydro-7H-naphtho[8,7-g]benzofuran-10,11-dione | |||||
MOL007141 | DS46 | salvianolic acid g | |||||
MOL007143 | DS47 | salvilenone Ⅰ | |||||
MOL007071 | DS22 | przewaquinone f | |||||
MOL007145 | DS48 | salviolone | |||||
MOL007077 | DS23 | sclareol | |||||
MOL007150 | DS49 | (6S)-6-hydroxy-1-methyl-6-methylol-8,9-dihydro-7H-naphtho[8,7-g]benzofuran-10,11-quinone | |||||
MOL007079 | DS24 | tanshinaldehyde | |||||
MOL007081 | DS25 | danshenol B | |||||
MOL007151 | DS50 | tanshindiol B | |||||
MOL007082 | DS26 | danshenol A | |||||
MOL007152 | DS51 | przewaquinone E | |||||
MOL007085 | DS27 | salvilenone | |||||
MOL007154 | DS52 | tanshinone ⅡA | |||||
MOL007088 | DS28 | cryptotanshinone | |||||
MOL007155 | DS53 | (6S)-6-(hydroxymethyl)-1,6-dimethyl-8,9-dihydro-7H-naphtho[8,7-g]benzofuran-10,11-dione | |||||
MOL007093 | DS27 | dan-shexinkum d | |||||
MOL007094 | DS30 | danshenspiroketallactone | |||||
MOL007098 | DS31 | deoxyneocryptotanshinone | MOL007156 | DS54 | tanshinone Ⅵ |
靶点 | BC | CC | Degree | 靶点 | BC | CC | Degree |
---|---|---|---|---|---|---|---|
TP53 | 0.04934171 | 0.85263158 | 67 | MAPK1 | 0.01429982 | 0.75700935 | 55 |
IL6 | 0.05941081 | 0.84375000 | 66 | CXCL8 | 0.01427692 | 0.74311927 | 53 |
AKT1 | 0.05284671 | 0.84375000 | 66 | MMP9 | 0.01574800 | 0.73636364 | 52 |
VEGFA | 0.04702297 | 0.81818182 | 63 | FOS | 0.01272944 | 0.72321429 | 50 |
EGFR | 0.03042531 | 0.78640777 | 59 | FN1 | 0.00789343 | 0.70434783 | 47 |
PTGS2 | 0.02918504 | 0.77142857 | 57 | PPARG | 0.01693000 | 0.70434783 | 47 |
JUN | 0.01497720 | 0.77142857 | 57 | CYCS | 0.01297165 | 0.69827586 | 46 |
CASP3 | 0.01374627 | 0.75700935 | 56 | MAPK14 | 0.00668698 | 0.69230769 | 46 |
STAT3 | 0.01360398 | 0.76415094 | 56 | IL10 | 0.00447499 | 0.69827586 | 46 |
TNF | 0.02303751 | 0.76415094 | 56 | ERBB2 | 0.01147722 | 0.69827586 | 46 |
[1] |
Zhang SY, Fu JY, Guo XY, et al. Improvement cues of lesion absorption using the adjuvant therapy of traditional Chinese medicine Qinbudan tablet for retreatment pulmonary tuberculosis with standard anti-tuberculosis regimen. Infect Dis Poverty, 2020, 9(1):50. doi: 10.1186/s40249-020-00660-z.
doi: 10.1186/s40249-020-00660-z URL |
[2] | 上海中医药大学附属龙华医院. 科技成果登记表(应用技术类成果): 芩部丹片. 上海: 上海中医药大学附属龙华医院, 2008. |
[3] |
蒋洪. 复方芩部丹方治疗气阴亏虚型耐多药肺结核疗效观察. 现代中西医结合杂志, 2016, 25(22):2468-2470. doi: 10.3969/j.issn.1008-8849.2016.22.027.
doi: 10.3969/j.issn.1008-8849.2016.22.027 |
[4] |
陆城华, 鹿振辉, 张惠勇. 复方芩部丹方对气阴亏虚型耐多药肺结核患者生活质量的影响. 中医学报, 2015, 30(11):1566-1568. doi: 10.16368/j.issn.1674-8999.2015.11.541.
doi: 10.16368/j.issn.1674-8999.2015.11.541 |
[5] |
Ru J, Li P, Wang J, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform, 2014, 6:13. doi: 10.1186/1758-2946-6-13.
doi: 10.1186/1758-2946-6-13 URL |
[6] |
Szklarczyk D, Morris JH, Cook H, et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res, 2017, 45(D1):D362-D368. doi: 10.1093/nar/gkw937.
doi: 10.1093/nar/gkw937 URL |
[7] |
郑勇凤, 王佳婧, 傅超美, 等. 黄芩的化学成分与药理作用研究进展. 中成药, 2016, 38(1):141-147. doi: 10.3969/j.issn.1001-1528.2016.01.032.
doi: 10.3969/j.issn.1001-1528.2016.01.032 |
[8] | 樊兰兰, 陆丽妃, 王孝勋, 等. 百部药理作用与临床应用研究进展. 中国民族民间医药, 2017, 26(8):55-59. |
[9] |
代晓光, 苏长兰. 丹参化学成分及药理研究进展. 中医药信息, 2018, 35(4):126-129. doi: 10.19656/j.cnki.1002-2406.180135.
doi: 10.19656/j.cnki.1002-2406.180135 |
[10] |
万新焕, 王瑜亮, 周长征, 等. 丹参化学成分及其药理作用研究进展. 中草药, 2020, 51(3):788-798. doi: 10.7501/j.issn.0253-2670.2020.03.032.
doi: 10.7501/j.issn.0253-2670.2020.03.032 |
[11] | 杜德兵, 罗世珍, 余平, 等. 黄芪联合丹参预防肺结核肺纤维化的研究. 中国防痨杂志, 2007, 29(4):339-342. |
[12] |
王莉新, 吴燕燕, 王易. “芩部丹”中三种单体对结核分枝杆菌作用下TLR2表达的影响. 中国药理学通报, 2011, 27(9):1284-1287. doi: 10.3969/j.issn.1001-1978.2011.09.024.
doi: 10.3969/j.issn.1001-1978.2011.09.024 |
[13] | 高薪. 三种中药成分的提取及其抗结核作用的初步研究. 长春: 吉林农业大学, 2011. |
[14] | 凌云飞, 李田歌, 曹嵘. 等. 木犀草素对体外循环导致急性肺损伤的保护作用及其机制研究[J/OL]. 中国胸心血管外科临床杂志, 2021[2021-08-02]. http://kns.cnki.net/kcms/detail/51.1492.R.20210721.1003.012.html. |
[15] | 任晓东, 符伟, 张晓芸, 等. 天然产物汉黄芩素的研究进展. 中国新药杂志, 2011, 20(9):777-784. |
[16] |
关震平. 黄芩及其主要成份抗菌作用研究. 陕西中医, 2018, 39(8):1148-1150. doi: 10.3969/j.issn.1000-7369.2018.08.048.
doi: 10.3969/j.issn.1000-7369.2018.08.048 |
[17] |
赵丰权, 戴建义, 李君桦, 等. 黄芩苷体内抑制结核分枝杆菌的机制研究. 预防医学, 2019, 31(10):998-1000,1006. doi: 10.19485/j.cnki.issn.2096-5087.2019.10.006.
doi: 10.19485/j.cnki.issn.2096-5087.2019.10.006 |
[18] |
Yuk JE, Woo JS, Yun CY, et al. Effects of lactose-beta-sitosterol and beta-sitosterol on ovalbumin-induced lung inflammation in actively sensitized mice. Int Immunopharmacol, 2007, 7(12):1517-1527. doi: 10.1016/j.intimp.2007.07.026.
doi: 10.1016/j.intimp.2007.07.026 URL |
[19] |
Liu R, Hao D, Xu W, et al. β-Sitosterol modulates macrophage polarization and attenuates rheumatoid inflammation in mice. Pharm Biol, 2019, 57(1):161-168. doi: 10.1080/13880209.2019.1577461.
doi: 10.1080/13880209.2019.1577461 URL |
[20] |
Pan MH, Lai CS, Wang YJ, et al. Acacetin suppressed LPS-induced up-expression of iNOS and COX-2 in murine macrophages and TPA-induced tumor promotion in mice. Biochem Pharmacol, 2006, 72(10):1293-1303. doi: 10.1016/j.bcp.2006.07.039.
doi: 10.1016/j.bcp.2006.07.039 URL |
[21] |
Ma Z, Ji W, Fu Q, et al. Formononetin inhibited the inflammation of LPS-induced acute lung injury in mice associated with induction of PPAR gamma expression. Inflammation, 2013, 36(6):1560-1566. doi: 10.1007/s10753-013-9700-5.
doi: 10.1007/s10753-013-9700-5 URL |
[22] | 谭国英, 张朝凤, 张勉. 野生直立百部的化学成分. 中国药科大学学报, 2007, 38(6):499-501. |
[23] |
王媛, 白贵斌, 王娟, 等. p53信号通路在MTB感染肺泡Ⅱ型上皮细胞系A549中的免疫调控作用. 西北农林科技大学学报(自然科学版), 2019, 47(8):8-16. doi: 10.13207/j.cnki.jnwafu.2019.08.002.
doi: 10.13207/j.cnki.jnwafu.2019.08.002 |
[24] |
张更伟, 欧敏, 周雪峰, 等. miR-20a-5p在结核分枝杆菌感染的人巨噬细胞中负向调控Jnk2基因的表达. 新发传染病电子杂志, 2021, 6(3):198-201. doi: 10.19871/j.cnki.xfcrbzz.2021.03.007.
doi: 10.19871/j.cnki.xfcrbzz.2021.03.007 |
[25] |
Jung BG, Wang X, Yi N, et al. Early Secreted Antigenic Target of 6-kDa of Mycobacterium tuberculosis Stimulates IL-6 Production by Macrophages through Activation of STAT3. Sci Rep, 2017, 7:40984. doi: 10.1038/srep40984.
doi: 10.1038/srep40984 URL |
[26] |
Hwang IK, Paik SS, Lee SH. Impact of Pulmonary Tuberculosis on the EGFR Mutational Status and Clinical Outcome in Patients with Lung Adenocarcinoma. Cancer Res Treat, 2019, 51(1):158-168. doi: 10.4143/crt.2018.084.
doi: 10.4143/crt.2018.084 URL |
[27] |
Chiba Y, Suto W, Sakai H. Augmented Pla2g4c/Ptgs2/Hpgds axis in bronchial smooth muscle tissues of experimental asthma. PLoS One, 2018, 13(8):e0202623. doi: 10.1371/journal.pone.0202623.
doi: 10.1371/journal.pone.0202623 URL |
[28] |
陈柯宇, 贲涵芝, 毛泽斌. 罗米地辛与阿糖胞苷联合用药在肺腺癌细胞中介导组蛋白H3K14乙酰化提高CASP3转录活性. 中国生物化学与分子生物学报, 2020, 36(3):319-327. doi: 10.13865/j.cnki.cjbmb.2020.02.1458.
doi: 10.13865/j.cnki.cjbmb.2020.02.1458 |
[29] | 唐神结, 肖和平, 范以虎, 等. 肺结核患者血清前炎细胞因子及其受体的变化. 中华结核和呼吸杂志, 2002, 25(6):325-329. |
[30] |
刘婷, 向延根, 范任华, 等. 肺结核病人细胞因子的研究进展. 实用预防医学, 2016, 23(7):894-897. doi: 10.3969/j.issn.1006-3110.2016.07.040.
doi: 10.3969/j.issn.1006-3110.2016.07.040 |
[31] |
Duan L, Gan H, Golan DE, et al. Critical role of mitochondrial damage in determining outcome of macrophage infection with Mycobacterium tuberculosis. J Immunol, 2002, 169(9):5181-5187. doi: 10.4049/jimmunol.169.9.5181.
doi: 10.4049/jimmunol.169.9.5181 pmid: 12391235 |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||